Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3C
pubmed:dateCreated
2003-8-20
pubmed:abstractText
Urokinase-type plasminogen activator (u-PA) has been reported to overexpress in several types of human cancers and correlate with cancer progression. The present study was performed to evaluate the significance of expression of u-PA on the progression of prostate cancer.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0250-7005
pubmed:author
pubmed:issnType
Print
pubmed:volume
23
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2945-50
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed:articleTitle
Clinical significance of expression of urokinase-type plasminogen activator in patients with prostate cancer.
pubmed:affiliation
Department of Urology, Faculty of Medicine, Toyama Medical and Pharmaceutical University, 2630, Sugitani, Toyama, Japan.
pubmed:publicationType
Journal Article